- Home
- ALRM vs SRPT Comparison
ALRM vs SRPT Comparison
Compare ALRM & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALRM | SRPT |
|---|---|---|
| Founded | 2000 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.5B |
| IPO Year | 2015 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ALRM | SRPT |
|---|---|---|
| Price | $49.47 | $19.17 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 29 |
| Target Price | ★ $56.67 | $25.85 |
| AVG Volume (30 Days) | 583.7K | ★ 3.5M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.42 | N/A |
| EPS | 0.47 | ★ 2.88 |
| Revenue | $1,011,187,000.00 | ★ $2,198,237,000.00 |
| Revenue This Year | $7.00 | N/A |
| Revenue Next Year | $4.53 | N/A |
| P/E Ratio | $105.72 | ★ $6.69 |
| Revenue Growth | 7.59 | ★ 15.58 |
| 52 Week Low | $41.49 | $10.42 |
| 52 Week High | $59.53 | $25.32 |
Technical Indicators
Market Signals| Indicator | ALRM | SRPT |
|---|---|---|
| Relative Strength Index (RSI) | 69.28 | 63.84 |
| Support Level | $48.13 | $15.50 |
| Resistance Level | $52.28 | $19.70 |
| Average True Range (ATR) | 1.63 | 0.96 |
| MACD | 0.45 | 0.40 |
| Stochastic Oscillator | 98.51 | 93.85 |
Price Performance
Historical ComparisonAbout ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.